Endometrial Cancer Trial, Recruiting NCT06749847 Sponsor: International Agency for Research on Cancer Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06749847
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 30 and 65 years old
  • You live in the Marne or Aube departments in France
  • You are due for routine cervical cancer screening and have received your first invitation letter (not a reminder letter) for this screening round

Who may not be able to join:

  • You are younger than 30 or 66 years old or older
  • You have already taken part in the current round of cervical cancer screening
  • You have had a complete hysterectomy (an operation to remove your whole womb)
  • You have previously been diagnosed with cervical cancer
  • You are currently being monitored or followed up because of an abnormal cervical screening result or a known problem with your cervix

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aurélie BERTRAND-BRICE, MD, Regional Cancer Screening Coordinating Centre, Marne site

Phone: +33 4 72738485

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
International Agency for Research on Cancer
Registry
ClinicalTrials.gov
Start date
26 June 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Participation rate in cervical cancer screening

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov